Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ASTX030 |
Synonyms | |
Therapy Description |
ASTX030 is a combination of azacitidine and cedazuridine, which may lead to inhibition of cell proliferation of tumor cells (Blood (2019) 134 (Supplement_1): 1376). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ASTX030 | ASTX 030|ASTX-030|AZA/CDZ Combination|Cedazuridine + Azacitidine | ASTX030 is a combination of azacitidine and cedazuridine, which may lead to inhibition of cell proliferation of tumor cells (Blood (2019) 134 (Supplement_1): 1376). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04256317 | Phase III | ASTX030 ASTX030 + Azacitidine ASTX030 + Azacitidine + Cedazuridine | A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML | Active, not recruiting | USA | CAN | 0 |